2018-2019
Weight Loss Prostate
Weight Loss Prostate
Weight Loss for Obese Prostate Cancer Patients on Androgen Deprivation Therapy
| TRIAL TITLE | Weight Loss for Obese Prostate Cancer Patients on Androgen Deprivation Therapy |
| CANCER TYPE | Prostate |
| TRIAL STATUS | Completed |
| PATIENT POPULATION | Men with prostate cancer receiving ADT for a minimum of 6 months, anticipated to remain on ADT for the entire study period, and being obese, defined as a body fat percentage ≥25%. |
| ACKNOWLEDGEMENTS | NHMRC Centre for Research Excellence in Prostate Cancer Survivorship |
